Identification of a new series of non-peptidic NK3 receptor antagonists-Reference-Cited by-同舟云学术

Identification of a new series of non-peptidic NK3 receptor antagonists

Published:2011-03 Issue:5 Volume:21 Page:1498-1501
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Juhl Karsten,Hansen Tore,Kehler Jan,Khanzhin Nikolay A.,Nørgaard Morten B.,Ruhland Thomas,Larsen Dorrit B.,Jensen Klaus G.,Steiniger-Brach Björn,Nielsen Søren M.,Simonsen Klaus B.

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference13 articles.

1. Detailed distribution of Neurokinin 3 receptors in the rat, guinea pig and gerbil brain: a comparative autoradiographic study

2. Distribution and pharmacological characterization of primate NK-1 and NK-3 tachykinin receptors in the central nervous system of the rhesus monkey

3. Species differences in tachykinin receptor distribution: Further evidence that the substance P (NK1) receptor predominates in human brain

4. Neurokinin-3 receptor antagonists in schizophrenia

5. Neurokinin 3 (NK3) Receptor Modulators for the Treatment of Psychiatric Disorders

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 2-Phenylcyclopropylmethylamine (PCPMA) as a privileged scaffold for central nervous system drug design;Bioorganic & Medicinal Chemistry Letters;2024-03

2. Neuropeptide Receptor Ligands for the Treatment of Schizophrenia: Focus on Neurotensin and Tachykinins;Current Pharmaceutical Design;2015-08-27

3. Convergent QSAR studies on a series of NK3 receptor antagonists for schizophrenia treatment;Journal of Enzyme Inhibition and Medicinal Chemistry;2015-04-09

4. Progress in the development of neurokinin 3 modulators for the treatment of schizophrenia: molecule development and clinical progress;Future Medicinal Chemistry;2013-09

5. Neuropeptide receptor ligands as drugs for psychiatric diseases: the end of the beginning?;Nature Reviews Drug Discovery;2012-05-18